CX-046684: 50 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
50
Total FAERS Reports
1 (2.0%)
Deaths Reported
16
Hospitalizations
50
As Primary/Secondary Suspect
2
Disabilities
First Report: 20180316 · Latest Report: 20250101
What Are the Most Common CX-046684 Side Effects?
#1 Most Reported
Fatigue
23 reports (46.0%)
#2 Most Reported
Off label use
15 reports (30.0%)
#3 Most Reported
Covid-19
14 reports (28.0%)
All CX-046684 Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 23 | 46.0% | 0 | 6 |
| Off label use | 15 | 30.0% | 0 | 3 |
| Covid-19 | 14 | 28.0% | 0 | 4 |
| Headache | 13 | 26.0% | 0 | 2 |
| Asthenia | 12 | 24.0% | 0 | 4 |
| Muscular weakness | 12 | 24.0% | 0 | 7 |
| Pain in extremity | 11 | 22.0% | 0 | 3 |
| Dysphagia | 10 | 20.0% | 0 | 2 |
| Dyspnoea | 10 | 20.0% | 0 | 3 |
| Fall | 10 | 20.0% | 0 | 4 |
| Drug ineffective | 9 | 18.0% | 0 | 3 |
| Insomnia | 9 | 18.0% | 0 | 3 |
| Gait disturbance | 8 | 16.0% | 0 | 1 |
| Malaise | 8 | 16.0% | 0 | 1 |
| Peripheral swelling | 8 | 16.0% | 0 | 2 |
| Arthralgia | 7 | 14.0% | 0 | 2 |
| Dizziness | 7 | 14.0% | 0 | 3 |
| Sars-cov-2 antibody test negative | 7 | 14.0% | 0 | 2 |
| Throat irritation | 7 | 14.0% | 0 | 0 |
| Visual impairment | 7 | 14.0% | 0 | 1 |
Who Reports CX-046684 Side Effects? Age & Gender Data
Gender: 74.0% female, 26.0% male. Average age: 48.8 years. Most reports from: DE. View detailed demographics →
Is CX-046684 Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 0 |
| 2019 | 7 | 0 | 2 |
| 2020 | 4 | 0 | 2 |
| 2021 | 10 | 1 | 5 |
| 2022 | 6 | 0 | 0 |
| 2023 | 4 | 0 | 4 |
| 2025 | 1 | 0 | 1 |
What Is CX-046684 Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 19 |
| Covid-19 immunisation | 12 |
| Covid-19 prophylaxis | 12 |
Official FDA Label for CX-046684
Official prescribing information from the FDA-approved drug label.